)
Visual
test
Zomedica
Zomedica (ZOM) investor relations material
Zomedica Status update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status update summary23 Jan, 2026
Strategic focus and technology innovation
Advancing animal health through practical innovation and expanding digital capabilities, with a focus on technology and digital innovation to drive growth, improve clinical outcomes, and strengthen practice economics.
Emphasis on five pillars: improving pet care quality, enhancing pet parent satisfaction, streamlining veterinary workflow, supporting veterinarian cash flow, and increasing clinic profitability.
Investment in AI, connected devices, cloud platforms, and interpretation tools to create integrated product experiences and data-driven insights.
Market trends and digital transformation
AI adoption in animal health is projected to grow at an 18% CAGR, with the market reaching nearly $7 billion by 2033.
Pet tech spending and telehealth are rapidly expanding, with integrated health platforms combining in-clinic and at-home data becoming the industry standard.
Zomedica's digital transformation includes the MyZomedica platform, mobile apps, e-commerce, and over-the-air software updates, supporting scalable growth.
Product and platform development
Launched TRUVIEW AI for object detection and classification in diagnostics, and expanded VetGuardian onboarding and monitoring capabilities.
Utilization-based models and cloud-driven enhancements increase device lifetime value and recurring revenue.
PIMS integration targeted for completion by end of Q2, enabling seamless workflow and data exchange with veterinary clinics.
How does PIMS integration enhance product adoption?
What operating leverage is expected post-$55M revenue?
What is the strategy for future Rahm-like agreements?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebOMCL
2025 revenue and ARR rose, recurring revenue hit 52%, and 2026 guidance signals further growth. - 5 FebSTC
Robust 2025 growth, margin expansion, and MCS acquisition support continued momentum. - 5 FebBMY
Growth Portfolio expansion and pipeline catalysts drive strong 2026 outlook despite legacy headwinds. - 5 FebPAHC
Net sales rose 21% and net income surged, prompting a raised outlook and strong margin gains. - 5 FebUGI
Q1 EBIT rose 5% to $441M, with strong gas demand and $215M in divestitures planned. - 5 FebBSANTANDER
Net income up 23% YoY, ROE/ROAE 23.5%, efficiency 36%, with strong digital and fee growth. - 5 FebCI
2025 revenue up 11% to $275B; 2026 EPS guidance at $30.25+ with ongoing PBM model changes. - 5 FebICE
Record revenue, double-digit EPS growth, and strong 2026 outlook across all segments. - 5 FebSTE
Q3 revenue up 9% and adjusted EPS at $2.53; 2026 outlook held despite $55M tariff impact. - 5 FebKGS
$675M acquisition expands distributed power reach, targeting data center growth and accretive returns.
Next Zomedica earnings date
Q4 202512 Mar, 2026
Zomedica
Next Zomedica earnings date
Q4 202512 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Zomedica Corpis a veterinary health company dedicated to developing and commercializing diagnostic and therapeutic products designed to meet the unmet needs of clinical veterinarians, focusing on companion animals. Zomedica's product offerings are primarily aimed at improving the diagnosis and treatment of diseases in companion animals, thereby advancing the field of veterinary medicine. The company is headquartered in Ann Arbor, Michigan, and its shares are listed on the NYSE.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage